Noneosinophilic responders with occupational asthma: A phenotype associated with a poor asthma prognosis - 01/03/14
, Simone Chaboillez, RT a, Abraham Bohadana, MD a, c, Lucie Blais, PhD a, b, Karim Maghni, PhD a, b| This study was funded by the cooperative agreement number R03 OH009734 from the Centers for Disease Control and Prevention and by Institut de recherche Robert-Sauvé en santé et en sécurité au travail. |
|
| Disclosure of potential conflict of interest: C. Lemiere has consultancy arrangements with GlaxoSmithKline, Merck, and AstraZeneca; has received one or more grants from or has one or more grants pending with AllerGen and Aerocrine; has received one or more payments for lecturing from or is on the speakers' bureau for AstraZeneca and Merck; has received royalties from UpToDate; and has received one or more payments for the development of educational presentations for AstraZeneca. L. Blais has consultancy arrangements with GlaxoSmithKline, AstraZeneca, and Pfizer and has received one or more grants from or has one or more grants pending with GlaxoSmithKline, AstraZeneca, Novartis, Merck, and Pfizer. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 133 - N° 3
P. 883 - mars 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
